Spineart completed enrollment for the U.S. investigational device exemption trial with the Baguera C cervical disc implant, the devicemaker said Feb. 29.
The trial will compare Baguera C in single-level cervical disc replacement to the Mobi-C , according to a news release. The trial will include about 300 patients across 30 study sites.
The Baguera C disc is designed to move in all six degrees of freedom and maintain the natural behavior of the spine. More than 60,000 implants have been sold globally since 2008.
Captiva Spine doubled its revenue year-over-year in the first quarter of 2025, largely due to accelerated market adoption of its…
Ten thousand patients have been treated with Augmedics’ Xvision augmented reality spine system, the company said April 22. The milestone…
The highest-paid CFO of orthopedic medtech companies in the U.S. saw more than $12 million per year in total compensation…
Comments are closed.